首页> 外国专利> HETEROCICLIC DERIVATIVES (INDOL-3-IL), AS CB1 CANNABINOID RECEPTOR AGONISTS.

HETEROCICLIC DERIVATIVES (INDOL-3-IL), AS CB1 CANNABINOID RECEPTOR AGONISTS.

机译:杂环衍生物(INDOL-3-IL),作为CB1大麻受体激动剂。

摘要

A heterocyclic (indole-3-yl) derivative having the general Formula I (See formula) where A represents a 5-membered aromatic heterocyclic ring, wherein X1, X2 and X3 are independently selected from N, O, S and CR; R is H or (C1-4) alkyl; or R, when present in X2 or X3, together with R3 can form a 5-8 member ring; R1 is a saturated carbocyclic ring of 5 to 8 members, which eventually contains a heteroatom selected from O and S; R2 is H, CH3 or CH2-CH3; or R2 joins together with R7 to form a 6-membered ring, which eventually contains a heteroatom selected from O and S, and whose heteroatom binds to position 7 of the indole ring; R3 and R4 are independently H, (C1-6) alkyl or (C3-7) cycloalkyl, the alkyl groups being optionally substituted with OH, C1-4 alkyloxy, C1-4 alkylthio, C1-4 alkylsulfonyl , CN or halogen; or R3, together with R4 and the N to which they are attached, form a 4-8 membered ring that eventually contains another heteroatom selected from O and S, and which is optionally substituted with OH, (C1-4) alkyl, alkyloxy ( C1-4), (C1-4) alkyloxy (C1-4) alkyl or halogen; or R3, together with R5, forms a 4-8 membered ring that eventually contains another heteroatom selected from O and S, and which is optionally substituted with OH, (C1-4) alkyl, (C1-4) alkyloxy, ( C1-4) (C1-4) alkyl or halogen; or R3, together with R, when present in X2 or X3, forms a 5-8 member ring; R5 is H or (C1-4) alkyl; or R5, together with R3, forms a 4-8 membered ring that eventually contains another heteroatom selected from O and S, and which is optionally substituted with OH, (C1-4) alkyl, (C1-4) alkyloxy, ( C1-4) (C1-4) alkyl or halogen; R5 '' is H or (C1-4) alkyl; R6 represents 1-3 substituents independently selected from H, (C1-4) alkyl, (C1-4) alkyloxy, CN and halogen; R7 is H, (C1-4) alkyl, (C1-4) alkyloxy, CN or halogen; or R7 joins R2 to form a 6-membered ring, which eventually contains another heteroatom selected from O and S, and whose heteroatom binds to position 7 of the indole ring; or a pharmaceutically acceptable salt thereof.
机译:具有通式I(参见式)的杂环(吲哚-3-基)衍生物,其中A表示5元芳族杂环,其中X 1,X 2和X 3独立地选自N,O,S和CR; R为H或(C1-4)烷基;当存在于X2或X3中时,R与R3一起形成5-8元环;或R1是5至8元的饱和碳环,其最终含有选自O和S的杂原子; R2为H,CH3或CH2-CH3;或R 2与R 7结合形成6元环,该环最终包含选自O和S的杂原子,并且该杂原子结合到吲哚环的7位; R3和R4独立地为H,(C1-6)烷基或(C3-7)环烷基,所述烷基任选地被OH,C1-4烷氧基,C1-4烷硫基,C1-4烷基磺酰基,CN或卤素取代; R3或R3与R4和它们所连接的N一起形成4-8元环,该环最终包含选自O和S的另一个杂原子,并且任选地被OH,(C1-4)烷基,烷氧基( C1-4),(C1-4)烷氧基(C1-4)烷基或卤素;或R 3与R 5一起形成4-8元环,该环最终包含选自O和S的另一个杂原子,并且其任选地被OH,(C 1-4)烷基,(C 1-4)烷氧基,(C 1- 4)(C1-4)烷基或卤素;当存在于X2或X3中时,R3与R一起形成5-8元环; R5是H或(C1-4)烷基;或R 5与R 3一起形成4-8元环,该环最终包含选自O和S的另一个杂原子,并且其任选地被OH,(C 1-4)烷基,(C 1-4)烷氧基,(C 1- 4)(C1-4)烷基或卤素; R5''为H或(C1-4)烷基; R6代表1-3个独立地选自H,(C1-4)烷基,(C1-4)烷氧基,CN和卤素的取代基; R7是H,(C1-4)烷基,(C1-4)烷氧基,CN或卤素;或R7与R2连接形成6元环,该环最终含有选自O和S的另一个杂原子,并且该杂原子结合到吲哚环的7位;或其药学上可接受的盐。

著录项

  • 公开/公告号ES2300995T3

    专利类型

  • 公开/公告日2008-06-16

    原文格式PDF

  • 申请/专利权人 N.V. ORGANON;

    申请/专利号ES20050716823T

  • 申请日2005-02-28

  • 分类号A61K31/4245;A61K31/4196;A61K31/422;A61K31/425;A61K31/427;A61K31/454;A61K31/5383;A61P29;C07D403/04;C07D409/04;C07D413/04;C07D413/14;C07D417/04;C07D417/14;C07D498/06;C07D513/04;

  • 国家 ES

  • 入库时间 2022-08-21 20:04:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号